166 related articles for article (PubMed ID: 7474896)
21. Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy.
Baumgartner MR; Dantas MF; Suormala T; Almashanu S; Giunta C; Friebel D; Gebhardt B; Fowler B; Hoffmann GF; Baumgartner ER; Valle D
Am J Hum Genet; 2004 Nov; 75(5):790-800. PubMed ID: 15359379
[TBL] [Abstract][Full Text] [Related]
22. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency.
Rinaldo P; Schmidt-Sommerfeld E; Posca AP; Heales SJ; Woolf DA; Leonard JV
J Pediatr; 1993 Apr; 122(4):580-4. PubMed ID: 8463904
[TBL] [Abstract][Full Text] [Related]
23. 3-Methylcrotonyl-CoA carboxylase deficiency: phenotypic variability in a family.
Eminoglu FT; Ozcelik AA; Okur I; Tumer L; Biberoglu G; Demir E; Hasanoglu A; Baumgartner MR
J Child Neurol; 2009 Apr; 24(4):478-81. PubMed ID: 19339287
[TBL] [Abstract][Full Text] [Related]
24. 3-Methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children.
Gibson KM; Bennett MJ; Naylor EW; Morton DH
J Pediatr; 1998 Mar; 132(3 Pt 1):519-23. PubMed ID: 9544913
[TBL] [Abstract][Full Text] [Related]
25. The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin.
Friebel D; von der Hagen M; Baumgartner ER; Fowler B; Hahn G; Feyh P; Heubner G; Baumgartner MR; Hoffmann GF
Neuropediatrics; 2006 Apr; 37(2):72-8. PubMed ID: 16773504
[TBL] [Abstract][Full Text] [Related]
26. Anesthetic management of a patient with 3-methylcrotonyl-CoA carboxylase deficiency.
Robbins KA; León-Ruiz EN
Anesth Analg; 2008 Aug; 107(2):648-50. PubMed ID: 18633047
[TBL] [Abstract][Full Text] [Related]
27. Partial 3-methylcrotonyl-CoA carboxylase deficiency in an infant with fatal outcome due to progressive respiratory failure.
Wiesmann UN; Suormala T; Pfenninger J; Baumgartner ER
Eur J Pediatr; 1998 Mar; 157(3):225-9. PubMed ID: 9537490
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.
Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR
Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551
[TBL] [Abstract][Full Text] [Related]
29. Inherited disorders of 3-methylcrotonyl CoA carboxylation.
Leonard JV; Seakins JW; Bartlett K; Hyde J; Wilson J; Clayton B
Arch Dis Child; 1981 Jan; 56(1):53-9. PubMed ID: 7469453
[TBL] [Abstract][Full Text] [Related]
30. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
[TBL] [Abstract][Full Text] [Related]
31. Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl.
Murayama K; Kimura M; Yamaguchi S; Shinka T; Kodama K
Brain Dev; 1997 Jun; 19(4):303-5. PubMed ID: 9187484
[TBL] [Abstract][Full Text] [Related]
32. Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiency.
Dirik E; Yiş U; Paşaoğlu G; Chambaz C; Baumgartner MR
Brain Dev; 2008 Mar; 30(3):218-20. PubMed ID: 17869468
[TBL] [Abstract][Full Text] [Related]
33. 3-Methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening.
Ficicioglu C; Payan I
Pediatrics; 2006 Dec; 118(6):2555-6. PubMed ID: 17142544
[TBL] [Abstract][Full Text] [Related]
34. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines.
Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB
Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency.
Baumgartner MR
J Inherit Metab Dis; 2005; 28(3):301-9. PubMed ID: 15868465
[TBL] [Abstract][Full Text] [Related]
36. L-carnitine therapy in propionicacidaemia.
Roe CR; Bohan TP
Lancet; 1982 Jun; 1(8286):1411-2. PubMed ID: 6123699
[No Abstract] [Full Text] [Related]
37. Improvement in exercise tolerance in isovaleric acidaemia with L-carnitine therapy.
Lee PJ; Harrison EL; Jones MG; Chalmers RA; Leonard JV; Whipp BJ
J Inherit Metab Dis; 1998 Apr; 21(2):136-40. PubMed ID: 9584264
[TBL] [Abstract][Full Text] [Related]
38. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency in two sibs.
Beemer FA; Bartlett K; Duran M; Ghneim HK; Wadman SK; Bruinvis L; Ketting D
Eur J Pediatr; 1982 Jul; 138(4):351-4. PubMed ID: 7128647
[TBL] [Abstract][Full Text] [Related]
39. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
[TBL] [Abstract][Full Text] [Related]
40. [3-Methylcrotonyl-CoA carboxylase deficiency].
Yoshida I
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):284-7. PubMed ID: 9590048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
